0002036372-24-000001.txt : 20240906 0002036372-24-000001.hdr.sgml : 20240906 20240906125625 ACCESSION NUMBER: 0002036372-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20240906 DATE AS OF CHANGE: 20240906 EFFECTIVENESS DATE: 20240906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OptoVista Holdings, LLC CENTRAL INDEX KEY: 0002036372 ORGANIZATION NAME: IRS NUMBER: 994025152 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523393 FILM NUMBER: 241283734 BUSINESS ADDRESS: STREET 1: 1200 G STREET, NW CITY: WASHINGTON STATE: DC ZIP: 20005 BUSINESS PHONE: 703-919-6983 MAIL ADDRESS: STREET 1: 1200 G STREET, NW CITY: WASHINGTON STATE: DC ZIP: 20005 D 1 primary_doc.xml X0708 D LIVE 0002036372 OptoVista Holdings, LLC 1200 G STREET, NW Suite 800 WASHINGTON DC DISTRICT OF COLUMBIA 20005 703-919-6983 DELAWARE None None Limited Liability Company true 2023 Matthew Rosini c/o Tern Therapeutics 1200 G Street NW, Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Executive Officer Alexander Bailey c/o Tern Therapeutics 1200 G Street NW, Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Executive Officer Director Christina Ohnsman c/o Tern Therapeutics 1200 G Street NW, Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Executive Officer Steven Oliveira c/o Tern Therapeutics 1200 G Street NW, Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Director Kerry Propper c/o Tern Therapeutics 1200 G Street NW, Suite 800 Washington DC DISTRICT OF COLUMBIA 20005 Director Biotechnology Decline to Disclose 06c false 2024-08-21 false true false 0 13978813 6978813 7000000 false 4 0 0 0 false OptoVista Holdings, LLC Matthew Rosini Matthew Rosini Chief Financial Officer 2024-09-06